IBDEI13C ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17715,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,17715,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,17716,0)
 ;;=Z08.^^61^791^41
 ;;^UTILITY(U,$J,358.3,17716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17716,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,17716,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,17716,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,17717,0)
 ;;=Z80.3^^61^791^42
 ;;^UTILITY(U,$J,358.3,17717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17717,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,17717,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,17717,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,17718,0)
 ;;=Z80.49^^61^791^43
 ;;^UTILITY(U,$J,358.3,17718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17718,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,17718,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,17718,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,17719,0)
 ;;=Z80.41^^61^791^44
 ;;^UTILITY(U,$J,358.3,17719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17719,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,17719,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,17719,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,17720,0)
 ;;=N73.9^^61^791^47
 ;;^UTILITY(U,$J,358.3,17720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17720,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,17720,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,17720,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,17721,0)
 ;;=N60.32^^61^791^48
 ;;^UTILITY(U,$J,358.3,17721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17721,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,17721,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,17721,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,17722,0)
 ;;=N60.31^^61^791^49
 ;;^UTILITY(U,$J,358.3,17722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17722,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,17722,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,17722,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,17723,0)
 ;;=Z01.411^^61^791^50
 ;;^UTILITY(U,$J,358.3,17723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17723,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,17723,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,17723,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,17724,0)
 ;;=Z01.419^^61^791^1
 ;;^UTILITY(U,$J,358.3,17724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17724,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,17724,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,17724,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,17725,0)
 ;;=Z01.419^^61^791^51
 ;;^UTILITY(U,$J,358.3,17725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17725,1,3,0)
 ;;=3^GYN Exam w/ Normal Findings
 ;;^UTILITY(U,$J,358.3,17725,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,17725,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,17726,0)
 ;;=R87.613^^61^791^53
 ;;^UTILITY(U,$J,358.3,17726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17726,1,3,0)
 ;;=3^HGSIL
 ;;^UTILITY(U,$J,358.3,17726,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,17726,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,17727,0)
 ;;=R87.612^^61^791^63
 ;;^UTILITY(U,$J,358.3,17727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17727,1,3,0)
 ;;=3^LGSIL
 ;;^UTILITY(U,$J,358.3,17727,1,4,0)
 ;;=4^R87.612
 ;;^UTILITY(U,$J,358.3,17727,2)
 ;;=^5019670
 ;;^UTILITY(U,$J,358.3,17728,0)
 ;;=R92.1^^61^791^66
 ;;^UTILITY(U,$J,358.3,17728,1,0)
 ;;=^358.31IA^4^2
